SEC Form 4 · accession 0001596771-16-000104
Diplomat Pharmacy, Inc. · DPLO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Atheer A Kaddis
Officer — EVP of Sales & Strategic Align
Period of report
Apr 15, 2016
Accepted (ET)
Apr 18, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610092
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 15, 2016 | M | 24,650 | $3.07 | A | 24,650 | D | |
| Common StockF1 | Apr 15, 2016 | S | 24,650 | $30.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option to Acquire Common StockF2 | $3.07 | Apr 15, 2016 | M | 24,650 | D | — | Apr 1, 2019 | Common Stock | 24,650 | 345,100 | D |
Explanation of responses
- F1The sale was effected pursuant to a 10b5-1 trading plan initially adopted by the reporting person on August 6, 2015. The plan provides for monthly sales of 12,325 shares of common stock at the market price. Shares that are not sold in a particular month will be available for sale in subsequent months under the plan. A maximum of 49,300 shares remain available for sale under the plan, which is set to expire on August 31, 2016.
- F2The options were granted on April 1, 2009. The options began to vest in annual increments of 25% of the option grant on the one-year anniversary of the grant date, to be fully vested after four years. 100% of the options originally granted are currently vested and exercisable.